Your session is about to expire
← Back to Search
Waterjet Ablation
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II (WATERII Trial)
N/A
Waitlist Available
Research Sponsored by PROCEPT BioRobotics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months post-treatment
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing the AQUABEAM System, which uses a high-speed stream of saltwater to remove extra prostate tissue. It targets men with urinary problems caused by an enlarged prostate. The treatment aims to improve symptoms by cutting away the problematic tissue without traditional surgery. Aquablation, using the AquaBeam system, is a new therapy that removes prostate tissue in men with urinary issues due to an enlarged prostate.
Eligible Conditions
- Enlarged Prostate
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months post-treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months post-treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Total International Prostate Symptom Score (IPSS) Score at 3 Months as Compared to Baseline
Incidence of Clavien-Dindo Adverse Events (Percentage of Participants) Through 3 Months Post Treatment
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Aquablation procedureExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Aquablation
2017
N/A
~110
Find a Location
Who is running the clinical trial?
PROCEPT BioRoboticsLead Sponsor
13 Previous Clinical Trials
1,220 Total Patients Enrolled